Diversify Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Diversify Advisory Services's REGN Position: Q2 2026 in Review
Diversify Advisory Services opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 1,211 shares worth $808K. The stake represents 0.01% of the portfolio and ranks #708 among its holdings. This is a return to the name: Diversify Advisory Services previously reported a position in REGN as recently as Q4 2024.
Diversify Advisory Services first reported a position in REGN in Q4 2024 and has held it in 2 quarters since. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Diversify Advisory Services held 1,211 shares of Regeneron Pharmaceuticals worth $808K as of Q2 2026.
- Regeneron Pharmaceuticals was a new Diversify Advisory Services position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.01% of Diversify Advisory Services's portfolio in Q2 2026, its #708 holding.
- Diversify Advisory Services first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 2 quarters since.
- 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.